Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Is the trillion-dollar Alphabet stock still a market-beating investment? Here's why this tech giant is just getting started.

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.

Months after that release, Alphabet and Google CEO Sundar Pichai ... Is that how you see generative AI? And project a little bit of the longer term future then how does this technology remake ...

The analyst highlighted several recent AI advancements from Alphabet that should help keep it ahead of the pack for the foreseeable future. These include “Project Mariner,” which can help ...

Alphabet has excellent financial performance, including significant revenue and net income growth. Read why GOOG stock is ...

Google also said Tuesday that it has been updating a new AI system to help researchers speed up their scientific and ...

Google raced to create a rival to ChatGPT, facing challenges and controversies along the way. Despite setbacks, analysts are ...

The article " Is Alphabet Too Cheap to Ignore After Its Recent Correction? " first appeared on MarketBeat.

The tech giant's withdrawal from new capacity leasing was largely led by the decision not to support additional training ...